- Home
- VNDA vs AWP Comparison
VNDA vs AWP Comparison
Compare VNDA & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VNDA | AWP |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.9M | 348.9M |
| IPO Year | 2005 | 2007 |
Fundamental Metrics
Financial Performance| Metric | VNDA | AWP |
|---|---|---|
| Price | $5.81 | $11.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.90 | N/A |
| AVG Volume (30 Days) | ★ 878.9K | 107.2K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $216,105,000.00 | N/A |
| Revenue This Year | $21.35 | N/A |
| Revenue Next Year | $37.40 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $4.14 | $3.78 |
| 52 Week High | $9.91 | $12.71 |
Technical Indicators
Market Signals| Indicator | VNDA | AWP |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 46.69 |
| Support Level | $5.11 | $11.48 |
| Resistance Level | $6.73 | $12.03 |
| Average True Range (ATR) | 0.27 | 0.16 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 23.97 | 42.24 |
Price Performance
Historical ComparisonAbout VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.